Italia -
italiano -
Ministero della Salute
dazide enhance
fine agrochemicals ltd - daminozide; - granulare idrodispersibile - 85.14 g i valori indicati sono per 100 g di prodotto. - fitoregolatore
Italia -
italiano -
Ministero della Salute
dazide enhance 85 wg
fine agrochemicals ltd - daminozide; - granulare idrodispersibile - 85.0 g i valori indicati sono per 100 g di prodotto. - fitoregolatore
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
hydroxychloroquine zentiva compresse rivestite con film
helvepharm ag - hydroxychloroquini sulfas - compresse rivestite con film - hydroxychloroquini sulfas 200 mg, excipiens pro compresso obducto. - la malaria, il lupus erythematodes, chronische poliartrite - synthetika
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
hydroxychloroquin-mepha 200 mg lactab
mepha pharma ag - hydroxychloroquini sulfas - lactab - hydroxychloroquini sulfas e 200 mg, maydis per amylum, calcio hydrogenophosphas dihydricus, silice colloidalis anhydrica, polysorbatum 80, talco, magnesio stearas, Überzug: hypromellosum, talco, e 171, macrogolum 6000, per compresso haze. - la malaria, il lupus erythematodes, chronische poliartrite - synthetika
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
hydroxychloroquin sandoz 200 mg compresse rivestite con film
sandoz pharmaceuticals ag - hydroxychloroquini sulfas - compresse rivestite con film - hydroxychloroquini sulfas 200.00 mg, calcii hydrogenophosphas dihydricus, povidonum, natrii hydrogenocarbonas corresp. natrium 0.27 mg, magnesii stearas, Überzug: hydroxypropylcellulosum, hypromellosum, e 171, macrogolum 400, macrogolum 8000, pro compresso obducto. - la malaria, il lupus erythematodes, chronische poliartrite - synthetika
Unione Europea -
italiano -
EMA (European Medicines Agency)
sitagliptin / metformin hydrochloride accord
accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabete mellito, tipo 2 - farmaci usati nel diabete - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. , triplice terapia di associazione) in aggiunta alla dieta e all'esercizio fisico in pazienti non adeguatamente controllati il loro dosaggio massimo tollerato di metformina ed una sulfonilurea. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.
Italia -
italiano -
Ministero della Salute
chloé eau de parfum vapo 50ml + lozione corpo 100ml
chloe' -